Collegium Pharmaceutical, Inc. COLL NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

66/100

4/7 Pass

SharesGrow Intrinsic Value

Collegium Pharmaceutical, Inc. (COLL) 的分析师一致评级为 Buy, 基于 12 位分析师覆盖该股票. 其中, 8 建议买入, 3 建议持有, and 1 建议卖出.

分析师对 COLL is $58.00, 代表 +66.0% 上涨空间较当前价格 $34.93. 目标价格区间从最低 $56.00 到最高 $60.00.

分析师共识 — COLL

Buy

强力买入

买入

持有

卖出

强力卖出

12 位分析师

价格目标

共识$58.00

最高$60.00

最低$56.00

中位数$58.00

上月均价-

上季均价$58.00

去年均价$57.40

历史总数13

其他人也在看

RGC

Regencell Bioscience Holdings Limited

$29.81

-1.00%

ITCI

Intra-Cellular Therapies, Inc.

$131.87

+0.00%

RDY

Dr. Reddy's Laboratories Limited

Prestige Consumer Healthcare Inc.

$57.57

+1.61%

PAHC

Phibro Animal Health Corporation

$55.01

-6.79%

ANIP

ANI Pharmaceuticals, Inc.

$76.48

-2.31%

PCRX

Pacira BioSciences, Inc.

$23.43

-1.35%

Collegium Pharmaceutical, Inc. COLL NASDAQ

分析师共识 — COLL

其他人也在看

获取低估股票提醒